Jomada, MB - financials and debts

Company age: 4 y. 8 mo.

Update

Jomada - Company finances

EUR
2022
From: 2022-01-07
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 98,074 132,365 168,559 131,952
Profit before tax -2,975 4,126 5,151 1,641
Net profit -2,975 3,889 4,858 1,530
Equity -2,974 914 5,773 7,303
Liabilities 15,113 10,090 12,729 34,106
Non-current assets 0 1,492 852 16,408
Current assets 12,139 9,512 17,650 25,001
Total assets 12,139 11,004 18,502 41,409
Taxes paid
STI taxes - 23,973 30,700 22,054
Financial indicators
Revenue change y/y - +35.0% +27.3% -21.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -24.5% 35.3% 26.3% 3.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 425.5% 84.2% 21.0%
Profit margin Net profit margin. Shows the overall profitability of the company. -3.0% 2.9% 2.9% 1.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -3.0% 3.1% 3.1% 1.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 11.0 2.2 4.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 98,074 70,075 88,715 131,952

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Jomada - Social security debts

From To Debt, €
2023-07-19 2023-07-20 322.45
2022-03-01 2022-03-17 50.95

Jomada - VMI tax arrears

From To Overdue, €
2026-09-02 2026-09-02 0.0
2026-08-31 2026-09-01 0.0
2026-08-30 2026-08-30 0.0
2026-08-28 2026-08-29 0.0
2026-08-26 2026-08-27 0.0
2026-08-25 2026-08-25 0.0
2026-08-23 2026-08-24 0.0
2026-08-20 2026-08-22 0.0
2026-08-19 2026-08-19 0.0
2026-08-18 2026-08-18 0.0
2026-08-17 2026-08-17 0.0
2026-08-13 2026-08-16 0.0
2026-08-12 2026-08-12 0.0
2026-08-10 2026-08-11 0.0
2026-08-09 2026-08-09 0.0
2026-08-07 2026-08-08 0.0
2026-08-05 2026-08-06 0.0
2026-08-03 2026-08-04 0.0
2026-07-26 2026-08-02 0.0
2026-07-07 2026-07-25 3401.92
2026-07-06 2026-07-06 3401.92
2026-06-30 2026-07-05 3401.92
2026-06-29 2026-06-29 3402.84
2026-06-05 2026-06-28 0.0
2026-06-04 2026-06-04 0.0
2026-06-02 2026-06-03 0.0
2026-06-01 2026-06-01 0.0
2026-05-31 2026-05-31 0.0
2026-05-29 2026-05-30 0.0
2026-05-28 2026-05-28 0.0
2026-05-26 2026-05-27 0.0
2026-05-25 2026-05-25 0.0
2026-05-22 2026-05-24 0.0
2026-05-20 2026-05-21 0.0
2026-05-19 2026-05-19 0.0
2026-05-18 2026-05-18 0.0
2026-05-17 2026-05-17 0.0
2026-05-14 2026-05-16 0.0
2026-05-13 2026-05-13 0.0
2026-05-12 2026-05-12 0.0
2026-05-11 2026-05-11 0.0
2026-05-10 2026-05-10 0.0
2026-05-06 2026-05-09 0.0
2026-05-03 2026-05-05 0.0
2026-05-01 2026-05-02 0.0
2026-04-29 2026-04-30 0.0
2026-04-28 2026-04-28 0.0
2026-04-27 2026-04-27 0.0
2026-04-26 2026-04-26 0.0
2026-04-24 2026-04-25 0.0
2026-04-23 2026-04-23 0.0
2026-04-22 2026-04-22 0.0
2026-04-20 2026-04-21 0.0
2026-04-17 2026-04-19 0.0
2026-04-15 2026-04-16 0.0
2026-04-14 2026-04-14 0.0
2026-04-13 2026-04-13 0.0
2026-04-12 2026-04-12 0.0
2026-04-10 2026-04-11 0.0
2026-04-09 2026-04-09 0.0
2026-04-08 2026-04-08 0.0
2026-04-02 2026-04-07 0.0
2026-03-29 2026-04-01 1416.0
2025-11-24 2025-11-24 0.0
2025-11-21 2025-11-23 0.0
2025-11-20 2025-11-20 0.0
2025-11-18 2025-11-19 0.0
2025-11-14 2025-11-17 0.0
2025-11-12 2025-11-13 0.0
2025-11-09 2025-11-11 17.66
2025-11-07 2025-11-08 0.0
2025-11-06 2025-11-06 0.0
2025-11-02 2025-11-05 0.0
2025-10-30 2025-11-01 0.0
2025-10-26 2025-10-29 0.0
2025-10-24 2025-10-25 3.1
2025-10-23 2025-10-23 3.1
2025-10-22 2025-10-22 3.1
2025-10-21 2025-10-21 3.1
2025-10-20 2025-10-20 3.1
2025-10-19 2025-10-19 3.1
2025-10-05 2025-10-18 3.1
2025-10-03 2025-10-04 3.1
2025-10-02 2025-10-02 3.1
2025-09-29 2025-10-01 3.1
2025-09-28 2025-09-28 3.1
2025-09-26 2025-09-27 0.0
2025-09-25 2025-09-25 0.0
2025-09-23 2025-09-24 0.0
2025-09-22 2025-09-22 0.0
2025-09-19 2025-09-21 0.0
2025-09-17 2025-09-18 0.0
2025-09-14 2025-09-16 0.0
2025-09-12 2025-09-13 0.0
2025-09-11 2025-09-11 0.0
2025-09-08 2025-09-10 0.0
2025-09-05 2025-09-07 0.0
2025-09-03 2025-09-04 0.0
2025-09-02 2025-09-02 0.0
2025-09-01 2025-09-01 0.0
2025-08-31 2025-08-31 0.0
2025-08-30 2025-08-30 0.0
2025-08-28 2025-08-29 1490.0
2025-01-25 2025-01-25 4.0
2025-01-22 2025-01-22 15.82
2024-12-27 2025-01-21 15.82
2024-12-25 2024-12-26 0.0
2024-12-24 2024-12-24 0.0
2024-12-23 2024-12-23 0.0
2024-12-22 2024-12-22 0.0
2024-12-20 2024-12-21 0.0
2024-12-19 2024-12-19 0.0
2024-12-18 2024-12-18 0.0
2024-12-17 2024-12-17 0.0
2024-12-16 2024-12-16 0.0
2024-12-15 2024-12-15 0.0
2024-12-13 2024-12-14 0.0
2024-12-12 2024-12-12 0.0
2024-12-11 2024-12-11 0.0
2024-12-10 2024-12-10 0.0
2024-12-08 2024-12-09 0.0
2024-12-06 2024-12-07 0.0
2024-12-05 2024-12-05 0.0
2024-12-04 2024-12-04 13.1
2024-12-03 2024-12-03 13.1
2024-11-29 2024-12-02 13.1
2024-11-28 2024-11-28 13.1
2024-11-27 2024-11-27 0.0
2024-11-26 2024-11-26 0.0
2024-11-25 2024-11-25 6.91
2024-11-24 2024-11-24 6.91
2024-11-22 2024-11-23 6.91
2024-11-20 2024-11-21 6.91
2024-11-18 2024-11-19 48.78
2024-11-17 2024-11-17 48.78
2024-10-16 2024-11-16 0.79
2024-10-14 2024-10-15 0.79
2024-10-10 2024-10-13 0.79
2024-10-09 2024-10-09 0.79
2024-10-07 2024-10-08 8.81

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Jomada, MB (code 305974633) is a small partnership engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of EUR 132.0K and net profit of EUR 1.5K, corresponding to a profit margin of 1.2%. Revenue decreased by 21.7% year on year, following EUR 168.6K in 2024 and EUR 132.4K in 2023, which indicates that sales fell back to the 2023 level after a stronger prior year. Profitability also softened over the period: net profit increased from EUR 3.9K in 2023 to EUR 4.9K in 2024, before declining to EUR 1.5K in 2025. At the end of 2025, total assets amounted to EUR 41.4K, equity to EUR 7.3K, and liabilities to EUR 34.1K. The equity ratio stood at 17.6%, while debt to equity was 4.67. Return on equity was 20.9% and return on assets 3.7%, supported by asset turnover of 3.19x. Revenue per employee was EUR 132.0K and profit per employee EUR 1.5K.